Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer

Clinical trial NCT05815927 · RECRUITING

Trial details

NCT number: NCT05815927
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Oligometastatic Squamous Cell Carcinoma of the Head and Neck

Start date: 2025-05-23
Primary completion: 2027-07-15
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.